Literature DB >> 31313122

Abnormal Liver Enzymes.

John Bian1, Andrew D Schreiner2, Don C Rockey2.   

Abstract

Year:  2019        PMID： 31313122      PMCID： PMC6712180          DOI： 10.1007/s11606-019-05172-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

Review 1.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

2.  Associations of Race with Follow-up Patterns After Initial Abnormal Liver Tests in Primary Care.

Authors:  John Bian; Andrew D Schreiner; Jingwen Zhang; Samuel O Schumann; Don C Rockey; Patrick D Mauldin; William P Moran
Journal:  J Gen Intern Med       Date:  2018-10       Impact factor: 5.128

3.  ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

Authors:  Paul Y Kwo; Stanley M Cohen; Joseph K Lim
Journal:  Am J Gastroenterol       Date:  2016-12-20       Impact factor: 10.864

4.  Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease.

Authors:  Myriam Alexander; A Katrina Loomis; Jolyon Fairburn-Beech; Johan van der Lei; Talita Duarte-Salles; Daniel Prieto-Alhambra; David Ansell; Alessandro Pasqua; Francesco Lapi; Peter Rijnbeek; Mees Mosseveld; Paul Avillach; Peter Egger; Stuart Kendrick; Dawn M Waterworth; Naveed Sattar; William Alazawi
Journal:  BMC Med       Date:  2018-08-13       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.